Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001493152-21-014742
Filing Date
2021-06-21
Accepted
2021-06-21 06:05:19
Documents
1
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 5601
  Complete submission text file 0001493152-21-014742.txt   7188
Mailing Address ONE BOSTON PLACE SUITE 2600 BOSTON MA 02108
Business Address ONE BOSTON PLACE SUITE 2600 BOSTON MA 02108 617-904-9195
Opaleye Management Inc. (Reporting) CIK: 0001595855 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-38738 | Film No.: 211027089

Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208 (847) 787-7361
Eton Pharmaceuticals, Inc. (Issuer) CIK: 0001710340 (see all company filings)

EIN.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations